The researchers noted that while severe COVID-19 can lead to breathing problems and high fever, some patients can experience diarrhea, nausea and vomiting, which suggests involvement of the gastrointestinal tract.
The team found that people who had received three-vaccine doses, those vaccinated after recovering from COVID-19, and those with a breakthrough infection had almost comparable neutralising antibody responses, in terms of magnitude and breadth.
The study conducted by Indian Council of Medical Research (ICMR) on COVID antibody reveals that sero prevalence may vary from state to state.
New York: Researchers have found that an antibody — originally developed for studying the autoimmune condition multiple sclerosis — can promote the immune system’s ability to fight cancer and decreases tumour growth. In a study published in the journal Science Immunology, the researchers reported that the antibody decreased tumour growth in models of melanoma (skin […]
New Delhi: India has received the much-awaited five lakh rapid COVID-19 testing kits from China and these are not meant for early diagnosis of the disease rather for monitoring whether coronavirus hotspots in India are increasing or showing a declining trend, the government said on Thursday. Addressing a daily briefing on COVID-19 situation in the […]
San Francisco: US-based Sorrento Therapeutics has announced that an antibody has demonstrated its ability to completely block SARS-CoV-2 infection of healthy cells in preclinical laboratory experiments. SARS-CoV-2 is the virus responsible for the COVID-19 pandemic. The results on Friday showed that Sorrento’s anti-SARS-CoV-2 antibody, STI-1499, completely neutralised the virus infectivity at a very low antibody […]
Copyright © 2024 - Odisha Television Limited All Rights Reserved.